This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
$5.3 million funding over 5 years approved for APAC MRDRRead more
We invite you to the free MRDR webinar: 5 Sept, 4-5pmRead more